The first successful cochlear implant in Latin America after severe aminoglycoside-induced ototoxicity in a Peruvian patient cured of extensively drug-resistant tuberculosis

Descripción del Articulo

Introduction: Multidrug-resistant tuberculosis is a significant public health problem for which drugs are used with many adverse effects. Among the devastating consequences of these diseases, there is a wide variation in the incidence of ototoxicity and hearing loss in patients with multidrug-resist...

Descripción completa

Detalles Bibliográficos
Autores: Pecho-Silva, Samuel, Navarro-Solsol, Ana Claudia, Panduro-Correa, Vicky, Maguina, Jorge L., Rabaan, Ali A., Quiroz-Ramirez, Luis Rene, Arteaga-Livias, Kovy, Rodriguez-Morales, Alfonso J.
Formato: artículo
Fecha de Publicación:2023
Institución:Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
Repositorio:Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
Lenguaje:español
OAI Identifier:oai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/1501
Enlace del recurso:https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1501
Nivel de acceso:acceso abierto
Materia:Tuberculosis
Extensively Drug-Resistant Tuberculosis
Hearing loss
Latin America
Tuberculosis X-DR
Pérdida de la audición
Latinoamérica
id REVCMH_dcec2dd97f88a30660ec34b207c70204
oai_identifier_str oai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/1501
network_acronym_str REVCMH
network_name_str Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
repository_id_str
spelling The first successful cochlear implant in Latin America after severe aminoglycoside-induced ototoxicity in a Peruvian patient cured of extensively drug-resistant tuberculosisPrimer implante coclear exitoso en América Latina después de ototoxicidad severa inducida por aminoglucósidos en un paciente peruano curado de una tuberculosis extremadamente resistente.Pecho-Silva, SamuelNavarro-Solsol, Ana ClaudiaPanduro-Correa, VickyMaguina, Jorge L. Rabaan, Ali A.Quiroz-Ramirez, Luis ReneArteaga-Livias, KovyRodriguez-Morales, Alfonso J.TuberculosisExtensively Drug-Resistant TuberculosisHearing lossLatin AmericaTuberculosisTuberculosis X-DRPérdida de la audiciónLatinoaméricaIntroduction: Multidrug-resistant tuberculosis is a significant public health problem for which drugs are used with many adverse effects. Among the devastating consequences of these diseases, there is a wide variation in the incidence of ototoxicity and hearing loss in patients with multidrug-resistant and extremely resistant tuberculosis. Cochlear implants may be indicated in patients with unilateral/severe bilateral hearing loss with no benefit from conventional hearing aids, but their use in patients with tuberculosis is rare. Case report: We present the first case of a right unilateral cochlear implant performed on a 34-year-old Peruvian patient who presented profound sensorineural hearing loss of cochlear origin. Conclusion: Cochlear implant surgery is an essential milestone in the treatment of patients with auditory sequelae of tuberculosis treatment. Close monitoring of possible complications of tuberculosis treatment should be strengthened in countries with a high incidence of multidrug-resistant and extremely resistant tuberculosis.Introducción: La tuberculosis multidrogorresistente es un importante problema de salud pública para el que se utilizan fármacos con múltiples efectos adversos. Entre las devastadoras consecuencias de estas enfermedades, existe una amplia variación en la incidencia de ototoxicidad y pérdida auditiva en pacientes con tuberculosis multirresistente y extremadamente resistente. Los implantes cocleares pueden estar indicados en pacientes con pérdida auditiva unilateral/bilateral severa sin beneficio de los audífonos convencionales, pero su uso en pacientes con tuberculosis es raro. Reporte de un caso: Presentamos el primer caso de implante coclear unilateral derecho realizado a un paciente peruano de 34 años que presentaba hipoacusia neurosensorial profunda de origen coclear. Conclusión: La cirugía de implante coclear es un hito fundamental en el tratamiento de los pacientes con secuelas auditivas del tratamiento de la tuberculosis. Se debe fortalecer la vigilancia estrecha de las posibles complicaciones del tratamiento de la tuberculosis en los países con una alta incidencia de tuberculosis multirresistente y extremadamente resistente.Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo2023-02-08info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionText Textoapplication/pdfhttps://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/150110.35434/rcmhnaaa.2022.154.1501Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 15 No. 4 (2022): October - December; 622 - 625Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 15 Núm. 4 (2022): Octubre - Diciembre; 622 - 6252227-47312225-510910.35434/rcmhnaaa.2022.154reponame:Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjoinstname:Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjoinstacron:HNAAAspahttps://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1501/745Derechos de autor 2023 Samuel Pecho-Silva, Ana Claudia Navarro-Solsol, Vicky Panduro-Correa, Jorge L. Maguina, Ali A. Rabaan, Luis Rene Quiroz-Ramirez, Kovy Arteaga-Livias, Alfonso J. Rodriguez-Moraleshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/15012023-05-29T03:22:34Z
dc.title.none.fl_str_mv The first successful cochlear implant in Latin America after severe aminoglycoside-induced ototoxicity in a Peruvian patient cured of extensively drug-resistant tuberculosis
Primer implante coclear exitoso en América Latina después de ototoxicidad severa inducida por aminoglucósidos en un paciente peruano curado de una tuberculosis extremadamente resistente.
title The first successful cochlear implant in Latin America after severe aminoglycoside-induced ototoxicity in a Peruvian patient cured of extensively drug-resistant tuberculosis
spellingShingle The first successful cochlear implant in Latin America after severe aminoglycoside-induced ototoxicity in a Peruvian patient cured of extensively drug-resistant tuberculosis
Pecho-Silva, Samuel
Tuberculosis
Extensively Drug-Resistant Tuberculosis
Hearing loss
Latin America
Tuberculosis
Tuberculosis X-DR
Pérdida de la audición
Latinoamérica
title_short The first successful cochlear implant in Latin America after severe aminoglycoside-induced ototoxicity in a Peruvian patient cured of extensively drug-resistant tuberculosis
title_full The first successful cochlear implant in Latin America after severe aminoglycoside-induced ototoxicity in a Peruvian patient cured of extensively drug-resistant tuberculosis
title_fullStr The first successful cochlear implant in Latin America after severe aminoglycoside-induced ototoxicity in a Peruvian patient cured of extensively drug-resistant tuberculosis
title_full_unstemmed The first successful cochlear implant in Latin America after severe aminoglycoside-induced ototoxicity in a Peruvian patient cured of extensively drug-resistant tuberculosis
title_sort The first successful cochlear implant in Latin America after severe aminoglycoside-induced ototoxicity in a Peruvian patient cured of extensively drug-resistant tuberculosis
dc.creator.none.fl_str_mv Pecho-Silva, Samuel
Navarro-Solsol, Ana Claudia
Panduro-Correa, Vicky
Maguina, Jorge L.
Rabaan, Ali A.
Quiroz-Ramirez, Luis Rene
Arteaga-Livias, Kovy
Rodriguez-Morales, Alfonso J.
author Pecho-Silva, Samuel
author_facet Pecho-Silva, Samuel
Navarro-Solsol, Ana Claudia
Panduro-Correa, Vicky
Maguina, Jorge L.
Rabaan, Ali A.
Quiroz-Ramirez, Luis Rene
Arteaga-Livias, Kovy
Rodriguez-Morales, Alfonso J.
author_role author
author2 Navarro-Solsol, Ana Claudia
Panduro-Correa, Vicky
Maguina, Jorge L.
Rabaan, Ali A.
Quiroz-Ramirez, Luis Rene
Arteaga-Livias, Kovy
Rodriguez-Morales, Alfonso J.
author2_role author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Tuberculosis
Extensively Drug-Resistant Tuberculosis
Hearing loss
Latin America
Tuberculosis
Tuberculosis X-DR
Pérdida de la audición
Latinoamérica
topic Tuberculosis
Extensively Drug-Resistant Tuberculosis
Hearing loss
Latin America
Tuberculosis
Tuberculosis X-DR
Pérdida de la audición
Latinoamérica
description Introduction: Multidrug-resistant tuberculosis is a significant public health problem for which drugs are used with many adverse effects. Among the devastating consequences of these diseases, there is a wide variation in the incidence of ototoxicity and hearing loss in patients with multidrug-resistant and extremely resistant tuberculosis. Cochlear implants may be indicated in patients with unilateral/severe bilateral hearing loss with no benefit from conventional hearing aids, but their use in patients with tuberculosis is rare. Case report: We present the first case of a right unilateral cochlear implant performed on a 34-year-old Peruvian patient who presented profound sensorineural hearing loss of cochlear origin. Conclusion: Cochlear implant surgery is an essential milestone in the treatment of patients with auditory sequelae of tuberculosis treatment. Close monitoring of possible complications of tuberculosis treatment should be strengthened in countries with a high incidence of multidrug-resistant and extremely resistant tuberculosis.
publishDate 2023
dc.date.none.fl_str_mv 2023-02-08
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Text
Texto
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1501
10.35434/rcmhnaaa.2022.154.1501
url https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1501
identifier_str_mv 10.35434/rcmhnaaa.2022.154.1501
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1501/745
dc.rights.none.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo
publisher.none.fl_str_mv Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo
dc.source.none.fl_str_mv Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 15 No. 4 (2022): October - December; 622 - 625
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 15 Núm. 4 (2022): Octubre - Diciembre; 622 - 625
2227-4731
2225-5109
10.35434/rcmhnaaa.2022.154
reponame:Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
instname:Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
instacron:HNAAA
instname_str Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
instacron_str HNAAA
institution HNAAA
reponame_str Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
collection Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1846434817944584192
score 13.041155
The first successful cochlear implant in Latin America after severe aminoglycoside-induced ototoxicity in a Peruvian patient cured of extensively drug-resistant tuberculosis
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).

Ejemplares Similares